文献速递生殖医学

不育与生育男性中线前列腺囊肿的患病率及囊肿大小与精液参数的关系

The prevalence of midline prostatic cysts and the relationship between cyst size and semen parameters among infertile and fertile men.
PubMed 文献 · Hum Reprod · 2018-01-01

横断面分析693例不育夫妇男性(648例纳入分析)与103例年龄匹配健康生育男性,不育男性中线前列腺囊肿(MPC)患病率10.2%,生育男性5.8%。MPC体积与精子总数负相关(r=-0.452,P<0.0001),生育男性最大MPC体积0.117 ml被作为生物阈值;>0.117 ml识别严重少精或弱精(原文为oligo- or azoospermia,即少精或死精/无精,按原文照录)的总体准确率约75%(均P<0.005)。

要点

  • 不育男性MPC患病率10.2%(66/648),生育男性5.8%(6/103)。
  • MPC体积与精子总数负相关(r=-0.452,P<0.0001)。
  • 生育男性最高MPC体积0.117 ml作为不损害精液质量的生物阈值。

核心结论

  • 不育男性MPC患病率10.2%,应按精液算法筛查MPC体积>0.117 ml者,该体积可能损害精液参数,可治疗以改善精子计数并实现自然妊娠。

研究设计与样本

  • 横断面分析2012年9月至2017年3月连续就诊的693例不育夫妇男性,另设103例年龄匹配健康生育男性为对照组。
  • 对11例接受经直肠超声引导囊肿抽吸(TRUCA)的不育男性进行纵向评估,术后1和3个月精液分析,术后1年随访自然妊娠。

主要发现

  • 不育男性MPC 66/648(10.2%),生育男性6/103(5.8%)。
  • 严重少精或无精患者MPC出现率和体积高于生育男性(均P<0.05)。
  • 不育MPC男性精液量、精子计数低于其余不育样本或生育男性,无精症患病率更高,提示射精管梗阻的超声征象更频繁。
  • MPC体积与精子总数负相关(r=-0.452,P<0.0001)。
  • 不育男性中MPC体积>0.117 ml识别严重少精或无精的总体准确率约75%(均P<0.005)。

关键数值与推荐

  • 生育男性最高MPC体积0.117 ml,提示为不损害精液质量的生物阈值。
  • 11例不育、精液异常且大MPC(>0.250 ml)者行TRUCA,术后1个月所有患者精子计数改善。
  • TRUCA后3个月精子计数低于术前2个月(P<0.005),MPC体积高于术前2个月(P<0.05),但均较基线改善。
  • TRUCA后4对夫妇自然妊娠。

临床怎么用

  • 作者提出基于精液参数的算法,用于在不育男性中识别需行前列腺超声的MPC患者。
  • 作者认为MPC体积≤0.117 ml可能不损害精液质量,更大体积可导致严重少精或无精并可治疗。
  • 作者认为TRUCA有效,较其他MPC手术技术更简单且侵入性更小。
  • 作者建议TRUCA后1个月考虑精液冷冻保存,因MPC可能增大且精子计数随时间下降。

局限性

  • 纵向评估治疗后MPC的不育男性数量有限(n=11),虽与既往研究样本量(n=7-20)一致。
  • 尽管MPC体积>0.117 ml可负面影响精子计数,本研究仅治疗了MPC>0.250 ml者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: When is the investigation and treatment of midline prostatic cysts (MPC) of clinical value in the work-up of males of infertile couples? SUMMARY ANSWER: With a prevalence of 10.2% in infertile men, MPC should be investigated according to a seminal algorithm detecting a MPC volume >0.117 ml, which may impair semen parameters, and could be treated to improve sperm count and achieve natural pregnancy. WHAT IS KNOWN ALREADY: MPC are frequent and are considered a correctable cause of male infertility. However, they have been poorly investigated in an infertility setting. In addition, no study has investigated clinical and ultrasound (US) characteristics of men with MPC. STUDY DESIGN, SIZE, DURATION: A cross-sectional analysis was carried out of 693 consecutive subjects consulting for couple infertility from September 2012 to March 2017. As a control group, 103 age-matched healthy, fertile men were studied. Furthermore, a longitudinal evaluation of 11 infertile men undergoing trans-rectal ultrasonically-guided cyst aspiration (TRUCA), semen analyses 1 and 3 months after TRUCA and a follow-up 1 year after TRUCA to assess natural pregnancy were performed. PARTICIPANTS/MATERIALS, SETTING, METHODS: All subjects underwent, in our outpatient clinic, clinical, hormonal, scrotal and transrectal US evaluation and semen analysis within the same day. Of 693 males of infertile couples, 648 (37.1 ± 7.9 years, mean+SD) without genetic abnormalities were studied, along with 103 fertile men (36.6 ± 5.0 years). Eleven infertile men underwent TRUCA and were followed-up as reported above. MAIN RESULTS AND THE ROLE OF CHANCE: A MPC was present in 66/648 (10.2%) males of infertile couples and in 6/103 (5.8%) fertile men. MPC occurrence and volume were higher in patients with severe oligo- or azoospermia than in fertile men (all P < 0.05). Infertile men with a MPC showed a lower seminal volume and sperm count and a higher prevalence of azoospermia than the rest of the infertile sample or fertile men, and a higher frequency of US signs suggestive of ejaculatory duct obstruction. MPC volume was negatively associated with total sperm count (r = -0.452, P < 0.0001). In fertile men, the highest MPC volume was 0.117 ml, suggesting it as a biological threshold not compromising semen quality. In infertile men, using receiver operating characteristic curve analyses, a MPC volume >0.117 ml identified subjects with severe oligo- or azoospermia with an overall accuracy of ~75% (both P < 0.005). Eleven men with infertility, semen abnormalities and large MPC (>0.250 ml) underwent TRUCA, which led to sperm count improvement in all patients 1 month after surgery. Three months after TRUCA a lower sperm count and a higher MPC volume than 2 months before were observed (P < 0.005 and P < 0.05, respectively), although improved when compared to baseline. After TRUCA a natural pregnancy occurred in four couples. Finally, we propose an algorithm, based on semen parameters, useful in identifying a MPC in males of infertile couples. LIMITATIONS, REASONS FOR CAUTION: Although in line with the sample size of previous studies (n = 7-20), the number of infertile men with MPC evaluated longitudinally after treatment is limited (n = 11). In addition, although a MPC volume >0.117 ml can negatively affect the sperm count, only MPC > 0.250 ml have been treated in this study. WIDER IMPLICATIONS OF THE FINDINGS: First, the algorithm proposed is easy to use and useful for selecting patients who can benefit from a prostate US in the infertility work-up. Second, a MPC volume ≤0.117 ml may not impair semen quality, while a larger volume can lead to severe oligo- or azoospermia and could be treated. Third, TRUCA is effective, and simpler and less invasive than other surgical techniques for MPC treatment. Finally, since the MPC can increase in size and sperm count decrease over time after TRUCA, semen cryopreservation should be considered 1 month after TRUCA. STUDY FUNDING/COMPETING INTEREST(S): Grants from the Ministry of University and Scientific Research (SIR project to F.L., protocol number: RBSI14LFMQ). No conflicts of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lotti F, Corona G, Cocci A, et al. The prevalence of midline prostatic cysts and the relationship between cyst size and semen parameters among infertile and fertile men. Hum Reprod. 2018. PMID: 30285122. doi:10.1093/humrep/dey298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。